Prefer Sun Pharma, Granules, Suven Life: Devang Mehta

Devang Mehta of Anand Rathi Financial Services told CNBC-TV18, "We continue to like pharma sector. In the largecap pharma space Sun Pharma is one stock which keeps us interested because though the valuations are little under expensive it is a class story. In fact the earnings have never disappointed in the past few quarters."

"In the midcap space we continue to like two excellent stories Granules India and Suven Life Sciences which qualifies as small to midcap stock. However both these companies present great opportunities in the segments that they are," he added.